These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 27803007)
1. Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force. Stauder R; Eichhorst B; Hamaker ME; Kaplanov K; Morrison VA; Österborg A; Poddubnaya I; Woyach JA; Shanafelt T; Smolej L; Ysebaert L; Goede V Ann Oncol; 2017 Feb; 28(2):218-227. PubMed ID: 27803007 [TBL] [Abstract][Full Text] [Related]
2. Management of unfit elderly patients with chronic lymphocytic leukemia. Eichhorst B; Hallek M; Goede V Eur J Intern Med; 2018 Dec; 58():7-13. PubMed ID: 30527922 [TBL] [Abstract][Full Text] [Related]
3. Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia. Innocenti I; Autore F; Pasquale R; Morelli F; Efremov DG; Laurenti L Expert Rev Hematol; 2017 Dec; 10(12):1069-1076. PubMed ID: 29082795 [TBL] [Abstract][Full Text] [Related]
4. Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology. Droz JP; Albrand G; Gillessen S; Hughes S; Mottet N; Oudard S; Payne H; Puts M; Zulian G; Balducci L; Aapro M Eur Urol; 2017 Oct; 72(4):521-531. PubMed ID: 28089304 [TBL] [Abstract][Full Text] [Related]
5. Management of elderly and unfit patients with chronic lymphocytic leukemia. Mauro FR; Salaroli A; Caputo MD; Colafigli G; Petrucci L; Campanelli M; Ferretti A; Guarini AR; Foà R Expert Rev Hematol; 2016 Dec; 9(12):1165-1175. PubMed ID: 27796157 [TBL] [Abstract][Full Text] [Related]
6. Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing Oncologist. Pinilla-Ibarz J; Emole J Cancer Control; 2015 Oct; 22(4 Suppl):7-16. PubMed ID: 26618341 [TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper. Morrison VA; Hamlin P; Soubeyran P; Stauder R; Wadhwa P; Aapro M; Lichtman S J Geriatr Oncol; 2015 Mar; 6(2):141-52. PubMed ID: 25491101 [TBL] [Abstract][Full Text] [Related]
8. Chronic Lymphocytic Leukemia in the Elderly: Epidemiology and Proposed Patient-Related Approach. Balducci L; Dolan D Cancer Control; 2015 Oct; 22(4 Suppl):3-6. PubMed ID: 26618340 [TBL] [Abstract][Full Text] [Related]
9. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. International CLL-IPI working group Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642 [TBL] [Abstract][Full Text] [Related]
11. Improving risk-stratification of patients with chronic lymphocytic leukemia using multivariate patient similarity networks. Turcsanyi P; Kriegova E; Kudelka M; Radvansky M; Kruzova L; Urbanova R; Schneiderova P; Urbankova H; Papajik T Leuk Res; 2019 Apr; 79():60-68. PubMed ID: 30852300 [TBL] [Abstract][Full Text] [Related]
12. What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017? Voorhies BN; Stephens DM Curr Treat Options Oncol; 2017 Feb; 18(2):12. PubMed ID: 28243993 [TBL] [Abstract][Full Text] [Related]
13. Management of elderly patients with chronic lymphocytic leukemia in the era of targeted therapies. Ysebaert L; Feugier P; Michallet AS Curr Opin Oncol; 2015 Sep; 27(5):365-70. PubMed ID: 26154708 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group. Goede V; Bahlo J; Chataline V; Eichhorst B; Dürig J; Stilgenbauer S; Kolb G; Honecker F; Wedding U; Hallek M Leuk Lymphoma; 2016; 57(4):789-96. PubMed ID: 26377031 [TBL] [Abstract][Full Text] [Related]
15. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation. Buccheri V; Barreto WG; Fogliatto LM; Capra M; Marchiani M; Rocha V Ann Hematol; 2018 Dec; 97(12):2269-2278. PubMed ID: 30315344 [TBL] [Abstract][Full Text] [Related]
16. Advances in the understanding of biology and prognosis in chronic lymphocytic leukemia. Zent CS; Kay NE Curr Oncol Rep; 2004 Sep; 6(5):348-54. PubMed ID: 15291975 [TBL] [Abstract][Full Text] [Related]
17. Prognostic markers and standard management of chronic lymphocytic leukemia. Stilgenbauer S Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745 [TBL] [Abstract][Full Text] [Related]
18. State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia. Cramer P; Hallek M; Eichhorst B Oncol Res Treat; 2016; 39(1-2):25-32. PubMed ID: 26890007 [TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease. Tees MT; Flinn IW Expert Rev Hematol; 2017 Feb; 10(2):137-146. PubMed ID: 27936980 [TBL] [Abstract][Full Text] [Related]